Back to search

Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure

Data up to Jan 2025

Published1988
Citations32
References24

Total Citations Per Year

Abstract

References (24)

An Introduction to Statistical Methods and Data Analysis

1994 • 5,244 citations

A new method for detecting anaerobic threshold by gas exchange

1986 • 3,936 citations

Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure

1981 • 899 citations

Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate.

1984 • 653 citations

A placebo-controlled trial of captopril in refractory chronic congestive heart failure

1983 • 562 citations

An Introduction to Statistical Methods and Data Analysis

1989 • 336 citations

Functional capacity of patients with chronic left ventricular failure

1979 • 273 citations

Measurement of absolute left ventricular volume from gated blood pool studies.

1982 • 264 citations

Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.

1986 • 175 citations

Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.

1983 • 147 citations

Membrane current changes responsible for the positive inotropic effect of OPC-8212, a new positive inotropic agent, in single ventricular cells of the guinea pig heart.

1987 • 89 citations

Application of a frequency definition of ventricular proarrhythmia

1987 • 66 citations

Validity of left-ventricular ejection fractions measured at rest and peak exercise by equilibrium radionuclide angiography using short acquisition times.

1979 • 56 citations

Changes in left ventricular function during recovery from upright bicycle exercise in normal persons and patients with coronary artery disease

1986 • 46 citations

In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.

1984 • 43 citations

Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy

1986 • 42 citations

Evidence for possible increase of sodium channel open time and involvement of Na/Ca exchange by a new positive inotropic drug: OPC-8212

1985 • 39 citations

Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure

1986 • 39 citations

Effects of amrinone on experimental acute myocardial ischaemic injury

1980 • 37 citations

New hope for the failing heart

1982 • 22 citations

Acute Hemodynamic Effects of a New Positive Inotropic Agent, 3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), in Conscious and Anesthetized Dogs

1986 • 18 citations

Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle.

1984 • 17 citations

Studies on the mechanism of action of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), a new positive inotropic drug. Enzyme activities and Ca2+ transport processes of sarcolemma and intracellular organelles.

1984 • 9 citations

Effects of OPC-8212, a New Positive Inotropic Agent, and Dobutamine on Left Ventricular Global and Ischemic Regional Functions and Coronary Hemodynamics Under Coronary Artery Stenosis

1986 • 8 citations

Cited By (0)

Loading...
Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy… (1988) – American Heart Journal | Metascience Observatory Explorer